Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders

Details for Australian Patent Application No. 2005322435 (hide)

Owner Epigenomics AG

Inventors Weiss, Gunter; Song, Xiaoling; Sledziewski, Andrew Z.; Distler, Jurgen; Skillman, Thomas L.; Model, Fabian; Cottrell, Susan; Haefliger, Carolina; Thomas, Jeffrey G.

Agent Davies Collison Cave

Pub. Number AU-B-2005322435

PCT Pub. Number WO2006/071466

Priority 60/662,220 14.03.05 US; 60/723,054 03.10.05 US; 60/740,736 30.11.05 US; 60/633,250 02.12.04 US; 60/723,125 03.10.05 US; 60/632,426 02.12.04 US

Filing date 2 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 23 February 2012

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/071466 Priority application(s): WO2006/071466

23 August 2007 Amendment Made

  The nature of the amendment is: Add the priority details 60/740,736 30 Nov 2005 US 2005325439 Nishihara, R. The nature of the amendment is: Amend the invention title to read Corpse treatment device

23 February 2012 Application Accepted

  Published as AU-B-2005322435

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005322439-2-(2 or 4-substituted aryloxy)-phenol derivatives as antibacterial agents

2005322432-Sandwich composite material using an air-laid process and wet glass